text stringlengths 377 3.32k |
|---|
{"timestamp": "2025-07-18 12:22:14.121", "mode": "azero-full", "language": "en", "target": "en", "text": "And we also have the opportunity to go beyond six weeks, namely around twelve weeks before we get into formal Phase two B, which I would say around next year, which we would go quite a bit longer. The sample size",... |
{"timestamp": "2025-07-18 12:22:19.617", "mode": "azero-full", "language": "en", "target": "en", "text": "what you've seen here maybe a little bit larger because of the multiple ascending dose?", "text_tts": "because of the multiple ascending dose", "translate": "what you've seen here maybe a little bit larger because ... |
{"timestamp": "2025-07-18 12:22:34.205", "mode": "azero-full", "language": "en", "target": "en", "text": "format here. We'll see larger sample sizes once we get into the formal Phase two B. The other opportunities here are also to look at titration at the one milligram or maybe even lower. We don't", "text_tts": "at th... |
{"timestamp": "2025-07-18 12:22:57.404", "mode": "azero-full", "language": "en", "target": "en", "text": "see any adverse events beyond suppression of appetite. So there's an opportunity to be able to start low and start titrating up to doses quite a bit higher than two milligrams. But we're open to watch this study an... |
{"timestamp": "2025-07-18 12:23:11.258", "mode": "azero-full", "language": "en", "target": "en", "text": "So those would be other things that will be evaluated as well as looking at dosing. The half life is around two hundred and seventy hours. So that could give us an opportunity to go twice a month and even potential... |
{"timestamp": "2025-07-18 12:23:18.979", "mode": "azero-full", "language": "en", "target": "en", "text": "So all that will be captured in this data set. We expect to see some data next year, and then that will", "text_tts": "", "translate": "So all that will be captured in this data set. We expect to see some data next... |
{"timestamp": "2025-07-18 12:23:23.438", "mode": "azero-full", "language": "en", "target": "en", "text": "allow us to best design a more formal Phase IIB study.", "text_tts": "IB study", "translate": "allow us to best design a more formal Phase IIB study.", "translate_tts": "allow us to best design a more formal Phase ... |
{"timestamp": "2025-07-18 12:23:27.063", "mode": "azero-full", "language": "en", "target": "en", "text": "Thanks, Terence. Operator, next question, please?", "text_tts": "e Operator next question please", "translate": "Thanks, Terence. Operator, next question, please?", "translate_tts": "Thanks Terence Operator next qu... |
{"timestamp": "2025-07-18 12:23:30.929", "mode": "azero-full", "language": "en", "target": "en", "text": "Next, we'll go to the line of Carter Gould from Cantor. Please go ahead.", "text_tts": "lease go ahead", "translate": "Next, we'll go to the line of Carter Gould from Cantor. Please go ahead.", "translate_tts": "Ne... |
{"timestamp": "2025-07-18 12:23:46.285", "mode": "azero-full", "language": "en", "target": "en", "text": "Good morning. Thanks for taking the question. Obviously, there's been a lot of discussion around drug pricing kind of resurfacing and some rumblings around Most Favored Nation kind of bubbling back to the surface. ... |
{"timestamp": "2025-07-18 12:23:53.233", "mode": "azero-full", "language": "en", "target": "en", "text": "ability, if need be, to take actions outside the US? And then maybe more of a commercial question as we think about", "text_tts": "a commercial question as we think about", "translate": "ability, if need be, to tak... |
{"timestamp": "2025-07-18 12:24:04.611", "mode": "azero-full", "language": "en", "target": "en", "text": "the potential co administration of Bonte and Botox. Can you kind of help frame how you think that would impact the market? Is this something that could just grow the overall pie, move share, et cetera? Any thoughts... |
{"timestamp": "2025-07-18 12:24:11.419", "mode": "azero-full", "language": "en", "target": "en", "text": "Hey, Carter, it's Rob. I'll take your first question, then Jeff will take the second question. I think the as we've", "text_tts": "question I think the as weve", "translate": "Hey, Carter, it's Rob. I'll take your ... |
{"timestamp": "2025-07-18 12:24:25.891", "mode": "azero-full", "language": "en", "target": "en", "text": "study the environment. We are very supportive of a balanced approach that addresses affordability while also encouraging innovation. And you've seen many of our peers reinforcing the importance for the EU to proper... |
{"timestamp": "2025-07-18 12:24:37.626", "mode": "azero-full", "language": "en", "target": "en", "text": "encourage that outcome. That said, we hope the administration contemplates the harm that international reference pricing could have on US health care the US health care industry and future innovation. I think anyth... |
{"timestamp": "2025-07-18 12:24:44.970", "mode": "azero-full", "language": "en", "target": "en", "text": "cost increases or higher taxes just leaves less investment available across the industry to advance new innovative medicines. That said,", "text_tts": "new innovative medicines That said", "translate": "cost increa... |
{"timestamp": "2025-07-18 12:24:59.461", "mode": "azero-full", "language": "en", "target": "en", "text": "I'm very encouraged by the administration's willingness to address the pill penalty in the IRA and as fixing that would support long term innovation in our industry. And so as we look at the push, I think, for the ... |
{"timestamp": "2025-07-18 12:25:02.072", "mode": "azero-full", "language": "en", "target": "en", "text": "innovation is an absolute appropriate push.", "text_tts": "ute appropriate push", "translate": "innovation is an absolute appropriate push.", "translate_tts": "innovation is an absolute appropriate push", "is_final... |
{"timestamp": "2025-07-18 12:25:15.731", "mode": "azero-full", "language": "en", "target": "en", "text": "We're encouraged by some of the policies that really support innovation. And Scott also talked about tax reform. And I think that's an important lever as well as we think about what are the things that will drive i... |
{"timestamp": "2025-07-18 12:25:29.871", "mode": "azero-full", "language": "en", "target": "en", "text": "and drive more innovation. I think if you just look at Abbie as an example, we've invested over five billion dollars of capital since tax reform in twenty seventeen. I mean, that includes a new oncology research ce... |
{"timestamp": "2025-07-18 12:25:30.480", "mode": "azero-full", "language": "en", "target": "en", "text": "in the U. S.", "text_tts": "in the U S", "translate": "in the U. S.", "translate_tts": "in the U S", "is_final": false, "emotion": "", "events": "👃👂🏠🔊", "think": "", "wav_name": "b5a761d0-948a-426e-8830-3ec3bd6... |
{"timestamp": "2025-07-18 12:25:45.510", "mode": "azero-full", "language": "en", "target": "en", "text": "high care capacity expansion in Waco, Texas and technology infrastructure upgrades across our footprint, just to name a few. And importantly, as Scott mentioned, tax reform allowed us to acquire Allergan, an Irish ... |
{"timestamp": "2025-07-18 12:26:08.790", "mode": "azero-full", "language": "en", "target": "en", "text": "action enabled Abbie to continue increasing our R and D investment through the Humera LOE, which is unprecedented. That will ultimately that will help us really lead to more innovation in our pipeline and ultimatel... |
{"timestamp": "2025-07-18 12:26:24.024", "mode": "azero-full", "language": "en", "target": "en", "text": "Yes. And thank you for the question. So let me give a quick update on the Bon T and the combination approach in terms of how we're starting to think about it. Obviously, we're super pleased with the recent filing o... |
{"timestamp": "2025-07-18 12:26:45.163", "mode": "azero-full", "language": "en", "target": "en", "text": "toxin will operate on two different levels for us. First, it will stimulate the funnel. It will basically be a market stimulator because we know there's lots of considerers in the marketplace that are just worried ... |
{"timestamp": "2025-07-18 12:26:52.975", "mode": "azero-full", "language": "en", "target": "en", "text": "works in about eight point five hours and is gone in two point five weeks makes the market much more approachable for the people in the consideration phase.", "text_tts": "phase", "translate": "works in about eight... |
{"timestamp": "2025-07-18 12:27:07.536", "mode": "azero-full", "language": "en", "target": "en", "text": "So we think it's going to work on the market and our share because obviously we've done studies with BOTOX after BONTI. Now in the combination used, Carter, it's very interesting. This is more of a pure sort of sha... |
{"timestamp": "2025-07-18 12:27:16.519", "mode": "azero-full", "language": "en", "target": "en", "text": "consumers, many of the consumers are using a lot of Botox, and you start saying, can you imagine a Botox that works almost immediately, so an immediate acting Botox?", "text_tts": "ely so an immediate acting Botox"... |
{"timestamp": "2025-07-18 12:27:31.076", "mode": "azero-full", "language": "en", "target": "en", "text": "That gives us the potential, and we'll have to see how those trials and those studies play out, to actually restate the whole market. Because what's remarkable about Bontee is that we can see a two grade change in ... |
{"timestamp": "2025-07-18 12:27:53.009", "mode": "azero-full", "language": "en", "target": "en", "text": "So nothing has ever worked even close to that fast. So we could even have a premium toxin that sits alongside BOTOX one day or a replacement product for just simply a better BOTOX, an immediate acting BOTOX. So it ... |
{"timestamp": "2025-07-18 12:27:53.987", "mode": "azero-full", "language": "en", "target": "en", "text": "Thanks, Carter.", "text_tts": "Thanks Carter", "translate": "Thanks, Carter.", "translate_tts": "Thanks Carter", "is_final": false, "emotion": "😊", "events": "📞🌠", "think": "", "wav_name": "b5a761d0-948a-426e-88... |
{"timestamp": "2025-07-18 12:27:56.316", "mode": "azero-full", "language": "en", "target": "en", "text": "Operator, next question, please?", "text_tts": "question please", "translate": "Operator, next question, please?", "translate_tts": "Operator next question please", "is_final": false, "emotion": "", "events": "📞🌠... |
{"timestamp": "2025-07-18 12:27:59.778", "mode": "azero-full", "language": "en", "target": "en", "text": "Next, we'll go to the line of Courtney Breen from Bernstein. Please go ahead.", "text_tts": "stein Please go ahead", "translate": "Next, we'll go to the line of Courtney Breen from Bernstein. Please go ahead.", "tr... |
{"timestamp": "2025-07-18 12:28:17.275", "mode": "azero-full", "language": "en", "target": "en", "text": "Hi all. Thanks for taking the question today. I wanted to loop back to kind of part of the inventory and tariff conversation. We've been able to get some explicit answers from some of the peer companies, so just wa... |
{"timestamp": "2025-07-18 12:28:31.908", "mode": "azero-full", "language": "en", "target": "en", "text": "enough inventory in the US to support products like Rinvox, Botox, Vraila or Humira for the rest of this year? And what about twenty six and twenty seven? And then the second question is just on the back of the Pri... |
{"timestamp": "2025-07-18 12:28:52.339", "mode": "azero-full", "language": "en", "target": "en", "text": "question. Can you give us a little bit of context as to the pricing strategy for that kind of pester market? Because arguably, kind of with a shorter directing time horizon, you have kind of less value. And so I'd ... |
{"timestamp": "2025-07-18 12:29:07.619", "mode": "azero-full", "language": "en", "target": "en", "text": "This is Rob. I'll take your first question and Jeff will take the second. Look, absent policy details, we're not going to get into speculating on the impact. I think you've known us to be a company that once we hav... |
{"timestamp": "2025-07-18 12:29:20.689", "mode": "azero-full", "language": "en", "target": "en", "text": "how we approached the Part D benefit redesign as soon as we understood that impact. We were well in advance of the implementation of that, discussing the impact on the company. But with tariffs, we don't have the p... |
{"timestamp": "2025-07-18 12:29:26.929", "mode": "azero-full", "language": "en", "target": "en", "text": "So it's premature to speculate on the impact. And once we have that information, we'll communicate at the appropriate time.", "text_tts": "have that information well communicate at the appropriate time", "translate... |
{"timestamp": "2025-07-18 12:29:42.335", "mode": "azero-full", "language": "en", "target": "en", "text": "Yes. And regarding the pricing, obviously, it's since we just had the filing, it's premature. We'd go through a very rigorous pricing analysis as we would get closer to the launch. And some of the considerations th... |
{"timestamp": "2025-07-18 12:29:45.849", "mode": "azero-full", "language": "en", "target": "en", "text": "of even more patients into the aesthetic practices.", "text_tts": "into the aesthetic practices", "translate": "of even more patients into the aesthetic practices.", "translate_tts": "of even more patients into the... |
{"timestamp": "2025-07-18 12:29:59.991", "mode": "azero-full", "language": "en", "target": "en", "text": "brings a lot of value to those practices. And if you think about it, the lifetime value of those new patients is very meaningful. So that could play into dynamics ultimately how we price the Bonti once we ultimatel... |
{"timestamp": "2025-07-18 12:30:22.493", "mode": "azero-full", "language": "en", "target": "en", "text": "sometime next year. Obviously, it does work shorter, so that might imply a different or lower price point to start the trial. But those are all considerations commercially that we will go through as we go through o... |
{"timestamp": "2025-07-18 12:30:23.826", "mode": "azero-full", "language": "en", "target": "en", "text": "Thanks Courtney.", "text_tts": "Thanks Courtney", "translate": "Thanks Courtney.", "translate_tts": "Thanks Courtney", "is_final": false, "emotion": "😊", "events": "📞🌠", "think": "", "wav_name": "b5a761d0-948a-4... |
{"timestamp": "2025-07-18 12:30:25.924", "mode": "azero-full", "language": "en", "target": "en", "text": "Operator, next question, please.", "text_tts": "ion please", "translate": "Operator, next question, please.", "translate_tts": "Operator next question please", "is_final": false, "emotion": "", "events": "📞🌠🏠🔊"... |
{"timestamp": "2025-07-18 12:30:30.276", "mode": "azero-full", "language": "en", "target": "en", "text": "Next, we'll go to the line of Mohit Bonsil from Wells Fargo. Please go ahead.", "text_tts": "om Wells Fargo Please go ahead", "translate": "Next, we'll go to the line of Mohit Bonsil from Wells Fargo. Please go ahe... |
{"timestamp": "2025-07-18 12:30:33.298", "mode": "azero-full", "language": "en", "target": "en", "text": "Ted, thank you very much for taking my question and congrats on all the progress.", "text_tts": "or taking my question and congrats on all the progress", "translate": "Ted, thank you very much for taking my questio... |
{"timestamp": "2025-07-18 12:30:48.183", "mode": "azero-full", "language": "en", "target": "en", "text": "I would like to understand a little bit more about your thought process around Gubras and Lin. And there have been a couple of strategies. So of course, Novo is trying to combine it with GLP one, but then there is ... |
{"timestamp": "2025-07-18 12:30:58.026", "mode": "azero-full", "language": "en", "target": "en", "text": "or thought process that Amlin could be a good agent as a stand alone agent. So how are you thinking about this, especially with the longer acting version?", "text_tts": "", "translate": "or thought process that Aml... |
{"timestamp": "2025-07-18 12:31:01.219", "mode": "azero-full", "language": "en", "target": "en", "text": "Do you think there's a strategy to just", "text_tts": "s a strategy to just", "translate": "Do you think there's a strategy to just", "translate_tts": "Do you think theres a strategy to just", "is_final": false, "e... |
{"timestamp": "2025-07-18 12:31:08.728", "mode": "azero-full", "language": "en", "target": "en", "text": "use this as a single agent, especially among patients who cannot tolerate Glyph one? We'd love to get your thoughts here. Thank you.", "text_tts": "thoughts here Thank you", "translate": "use this as a single agent... |
{"timestamp": "2025-07-18 12:31:15.375", "mode": "azero-full", "language": "en", "target": "en", "text": "Mohead, it's Rupal. I'll take that. So thanks for", "text_tts": "al Ill take that So thanks for", "translate": "Mohead, it's Rupal. I'll take that. So thanks for", "translate_tts": "Mohead its Rupal Ill take that S... |
{"timestamp": "2025-07-18 12:31:22.407", "mode": "azero-full", "language": "en", "target": "en", "text": "highlighting some of the potential here. And I think we're thinking about it quite broadly.", "text_tts": "were thinking about it quite broadly", "translate": "highlighting some of the potential here. And I think w... |
{"timestamp": "2025-07-18 12:31:36.505", "mode": "azero-full", "language": "en", "target": "en", "text": "So as you stated, there's an opportunity here as a monotherapy. I think the way we think about it is tolerability is key. We see a number of dropouts upwards of thirty percent sign even", "text_tts": "We see a numb... |
{"timestamp": "2025-07-18 12:31:52.051", "mode": "azero-full", "language": "en", "target": "en", "text": "after a month of starting with the current set of assets. And then when we look over the course of the year, sixty percent to seventy percent of the patients will drop. Now there's a variety of factors that drive t... |
{"timestamp": "2025-07-18 12:31:54.121", "mode": "azero-full", "language": "en", "target": "en", "text": "But a key component is", "text_tts": "component is", "translate": "But a key component is", "translate_tts": "But a key component is", "is_final": false, "emotion": "", "events": "📞🌠🏠🔊", "think": "", "wav_name"... |
{"timestamp": "2025-07-18 12:31:55.517", "mode": "azero-full", "language": "en", "target": "en", "text": "tolerability.", "text_tts": "tolerability", "translate": "tolerability.", "translate_tts": "tolerability", "is_final": false, "emotion": "", "events": "📞🌠🏠🔊", "think": "", "wav_name": "b5a761d0-948a-426e-8830-3... |
{"timestamp": "2025-07-18 12:32:03.280", "mode": "azero-full", "language": "en", "target": "en", "text": "So to have a monotherapy that's tolerable, that provides meaningful weight loss and potentially has other", "text_tts": "meaningful weight loss and potentially has other", "translate": "So to have a monotherapy tha... |
{"timestamp": "2025-07-18 12:32:17.319", "mode": "azero-full", "language": "en", "target": "en", "text": "potential benefits. We've seen preclinically preservation of muscle. We'll have to see if that plays out. But that could be another benefit in the long term. When this launches, we do anticipate many of the patient... |
{"timestamp": "2025-07-18 12:32:31.209", "mode": "azero-full", "language": "en", "target": "en", "text": "on assets that are available today. So it could serve as a nice follow on for folks that couldn't tolerate or came off for other reasons and want to go somewhere else.", "text_tts": "r reasons and want to go somewh... |
{"timestamp": "2025-07-18 12:32:33.907", "mode": "azero-full", "language": "en", "target": "en", "text": "Now in terms of combinations, recall,", "text_tts": "terms of combinations recall", "translate": "Now in terms of combinations, recall,", "translate_tts": "Now in terms of combinations recall", "is_final": false, "... |
{"timestamp": "2025-07-18 12:32:40.364", "mode": "azero-full", "language": "en", "target": "en", "text": "when we did this deal, one thing we liked about it was also the neutral pH of the formulation.", "text_tts": "", "translate": "when we did this deal, one thing we liked about it was also the neutral pH of the formu... |
{"timestamp": "2025-07-18 12:32:52.829", "mode": "azero-full", "language": "en", "target": "en", "text": "So that could enable combinations with a variety of mechanisms. And as Rob stated, we are interested continue to be interested in this space, and we'll be thinking about other", "text_tts": "ce and well be thinking... |
{"timestamp": "2025-07-18 12:32:57.539", "mode": "azero-full", "language": "en", "target": "en", "text": "potential opportunities, which could include combinations that may drive", "text_tts": "", "translate": "potential opportunities, which could include combinations that may drive", "translate_tts": "potential opport... |
{"timestamp": "2025-07-18 12:32:59.471", "mode": "azero-full", "language": "en", "target": "en", "text": "further weight loss.", "text_tts": "further weight loss", "translate": "further weight loss.", "translate_tts": "further weight loss", "is_final": false, "emotion": "", "events": "📞🌠🏠🔊", "think": "", "wav_name"... |
{"timestamp": "2025-07-18 12:33:05.392", "mode": "azero-full", "language": "en", "target": "en", "text": "But key for us would be tolerability and durable durability of use.", "text_tts": "durability of use", "translate": "But key for us would be tolerability and durable durability of use.", "translate_tts": "But key f... |
{"timestamp": "2025-07-18 12:33:08.886", "mode": "azero-full", "language": "en", "target": "en", "text": "Thanks, Mohit. Operator, next question, please.", "text_tts": "Operator next question please", "translate": "Thanks, Mohit. Operator, next question, please.", "translate_tts": "Thanks Mohit Operator next question p... |
{"timestamp": "2025-07-18 12:33:13.284", "mode": "azero-full", "language": "en", "target": "en", "text": "Next we'll go to the line of Steve Scala from TD Cowen. Please go ahead.", "text_tts": "Please go ahead", "translate": "Next we'll go to the line of Steve Scala from TD Cowen. Please go ahead.", "translate_tts": "N... |
{"timestamp": "2025-07-18 12:33:27.361", "mode": "azero-full", "language": "en", "target": "en", "text": "Thank you so much. Two questions. First of all, Bristol appears to think there's a path forward with cobenfi and adjuvant schizophrenia based on existing data. Where does AbbVie stand in its analysis of the future ... |
{"timestamp": "2025-07-18 12:33:31.859", "mode": "azero-full", "language": "en", "target": "en", "text": "For instance, has a path forward become more clear in the last few months?", "text_tts": "h forward become more clear in the last few months", "translate": "For instance, has a path forward become more clear in the... |
{"timestamp": "2025-07-18 12:33:32.543", "mode": "azero-full", "language": "en", "target": "en", "text": "Secondly,", "text_tts": "Secondly", "translate": "Secondly,", "translate_tts": "Secondly", "is_final": false, "emotion": "", "events": "👃👂", "think": "", "wav_name": "b5a761d0-948a-426e-8830-3ec3bd6c7e1c", "embed... |
{"timestamp": "2025-07-18 12:33:44.860", "mode": "azero-full", "language": "en", "target": "en", "text": "I believe AbbVie has more plants in Ireland than any other company. Curious how you think about that as well as your overall OUS footprint. Do you cut back OUS to invest in the US?", "text_tts": "to invest in the U... |
{"timestamp": "2025-07-18 12:33:51.685", "mode": "azero-full", "language": "en", "target": "en", "text": "or do you maintain the presence of US, given the fact that in four years, we could have a different administration with", "text_tts": "e a different administration with", "translate": "or do you maintain the presen... |
{"timestamp": "2025-07-18 12:33:53.002", "mode": "azero-full", "language": "en", "target": "en", "text": "very different views.", "text_tts": "very different views", "translate": "very different views.", "translate_tts": "very different views", "is_final": false, "emotion": "", "events": "👃👂", "think": "", "wav_name"... |
{"timestamp": "2025-07-18 12:33:56.961", "mode": "azero-full", "language": "en", "target": "en", "text": "And related to this topic, yesterday, Roche said", "text_tts": "this topic yesterday Roche said", "translate": "And related to this topic, yesterday, Roche said", "translate_tts": "And related to this topic yesterd... |
{"timestamp": "2025-07-18 12:34:04.362", "mode": "azero-full", "language": "en", "target": "en", "text": "that their US plants are fifty percent utilized. I'm wondering if AbbVie would share a similar percentage? Thank you.", "text_tts": "milar percentage Thank you", "translate": "that their US plants are fifty percent... |
{"timestamp": "2025-07-18 12:34:10.766", "mode": "azero-full", "language": "en", "target": "en", "text": "It's RuPal. I'll start with", "text_tts": "Ill start with", "translate": "It's RuPal. I'll start with", "translate_tts": "Its RuPal Ill start with", "is_final": false, "emotion": "", "events": "📞🌠🏠🔊", "think": ... |
{"timestamp": "2025-07-18 12:34:24.945", "mode": "azero-full", "language": "en", "target": "en", "text": "the schizophrenia questions. In terms of the recent data, it's difficult for us to comment. I think that will be a discussion between the company and health authorities regarding the utility of a failed study.", "t... |
{"timestamp": "2025-07-18 12:34:28.518", "mode": "azero-full", "language": "en", "target": "en", "text": "that would be their discussion to have", "text_tts": "ld be their discussion to have", "translate": "that would be their discussion to have", "translate_tts": "that would be their discussion to have", "is_final": f... |
{"timestamp": "2025-07-18 12:34:35.306", "mode": "azero-full", "language": "en", "target": "en", "text": "How we look at ameraclidine is that we do still see potential.", "text_tts": "ill see potential", "translate": "How we look at ameraclidine is that we do still see potential.", "translate_tts": "How we look at amer... |
{"timestamp": "2025-07-18 12:34:49.770", "mode": "azero-full", "language": "en", "target": "en", "text": "and we want to approach this in a stepwise manner. The first step would be to look to see if we can further dose escalate beyond what was previously studied. We saw variable", "text_tts": "t was previously studied ... |
{"timestamp": "2025-07-18 12:35:27.811", "mode": "azero-full", "language": "en", "target": "en", "text": "A levels in those patients from the pivotal studies, some were low, and we think there's an opportunity to raise that. So a multiple ascending dose study will be initiated this year, and that would apply to potenti... |
{"timestamp": "2025-07-18 12:35:38.787", "mode": "azero-full", "language": "en", "target": "en", "text": "And then if we see strong data there, which could be as a monotherapy, could be as an adjunct and also in neurodegeneration psychosis, then we would", "text_tts": "sis then we would", "translate": "And then if we s... |
{"timestamp": "2025-07-18 12:35:44.202", "mode": "azero-full", "language": "en", "target": "en", "text": "move into the Phase three setting. But I would say we still believe there's opportunity here.", "text_tts": "we still believe theres opportunity here", "translate": "move into the Phase three setting. But I would s... |
{"timestamp": "2025-07-18 12:36:00.565", "mode": "azero-full", "language": "en", "target": "en", "text": "And Steve, this is Rob. I'll take your question on the manufacturing footprint. As I mentioned in my remarks earlier, obviously, Abbie, we have a very broad footprint. An important part of the strategy is to assure... |
{"timestamp": "2025-07-18 12:36:13.617", "mode": "azero-full", "language": "en", "target": "en", "text": "without any supply disruptions, and that strategy certainly paid off. We also have, I'd say, a very robust manufacturing network in the US. I think what's been widely misunderstood is", "text_tts": "think whats bee... |
{"timestamp": "2025-07-18 12:36:18.884", "mode": "azero-full", "language": "en", "target": "en", "text": "Skyrizzy as an example, our largest product is made in the US. And so", "text_tts": "US And so", "translate": "Skyrizzy as an example, our largest product is made in the US. And so", "translate_tts": "Skyrizzy as a... |
{"timestamp": "2025-07-18 12:36:33.254", "mode": "azero-full", "language": "en", "target": "en", "text": "when we look at our global footprint, we consider assurance of supply. As Scott mentioned earlier, clearly, obviously, tax has an influence on longer term how you'd want to structure your supply chain. So certainly... |
{"timestamp": "2025-07-18 12:36:34.978", "mode": "azero-full", "language": "en", "target": "en", "text": "a more competitive tax policy,", "text_tts": "e tax policy", "translate": "a more competitive tax policy,", "translate_tts": "a more competitive tax policy", "is_final": false, "emotion": "", "events": "📞🌠🏠🔊", ... |
{"timestamp": "2025-07-18 12:36:50.129", "mode": "azero-full", "language": "en", "target": "en", "text": "that sort of provide the appropriate incentives. We try to say we have obviously been ramping our volume considerably. You look at just the performance, just it would then think about biologics capacity and just th... |
{"timestamp": "2025-07-18 12:37:12.816", "mode": "azero-full", "language": "en", "target": "en", "text": "invoke. And so we stay ahead of the curve. We ensure that we are investing appropriately so we can keep up with that demand. I'd say the commercial team puts a lot of pressure on operations because they're performi... |
{"timestamp": "2025-07-18 12:37:26.673", "mode": "azero-full", "language": "en", "target": "en", "text": "our volume growth that we expect, in addition to new areas that we will invest. For example, peptide manufacturing, as an example, as we enter that space, obviously, now as we enter into obesity, it makes sense to"... |
{"timestamp": "2025-07-18 12:37:35.253", "mode": "azero-full", "language": "en", "target": "en", "text": "add that capability. And so that will also be part of our supply chain strategy here. So that's the way we're thinking about it.", "text_tts": "thinking about it", "translate": "add that capability. And so that wil... |
{"timestamp": "2025-07-18 12:37:38.128", "mode": "azero-full", "language": "en", "target": "en", "text": "All right. Thanks, Steve. Operator. Next question, please.", "text_tts": "ve Operator Next question please", "translate": "All right. Thanks, Steve. Operator. Next question, please.", "translate_tts": "All right Th... |
{"timestamp": "2025-07-18 12:37:41.702", "mode": "azero-full", "language": "en", "target": "en", "text": "Next, we'll go to the line of Dave Reisinger from LeRinc Partners. Please go ahead.", "text_tts": "eRinc Partners Please go ahead", "translate": "Next, we'll go to the line of Dave Reisinger from LeRinc Partners. P... |
{"timestamp": "2025-07-18 12:37:46.860", "mode": "azero-full", "language": "en", "target": "en", "text": "Thanks very much. And congrats on the performance.", "text_tts": "much And congrats on the performance", "translate": "Thanks very much. And congrats on the performance.", "translate_tts": "Thanks very much And con... |
{"timestamp": "2025-07-18 12:37:48.935", "mode": "azero-full", "language": "en", "target": "en", "text": "So I have two questions, please.", "text_tts": "questions please", "translate": "So I have two questions, please.", "translate_tts": "So I have two questions please", "is_final": false, "emotion": "", "events": "📞... |
{"timestamp": "2025-07-18 12:37:57.191", "mode": "azero-full", "language": "en", "target": "en", "text": "and they're both a bit high level. So the first is the industry is facing three major US government risks", "text_tts": "major US government risks", "translate": "and they're both a bit high level. So the first is ... |
{"timestamp": "2025-07-18 12:38:07.317", "mode": "azero-full", "language": "en", "target": "en", "text": "actions that are harming biopharma innovation, including significant FDA disruption and questioning of proven medical science.", "text_tts": "", "translate": "actions that are harming biopharma innovation, includin... |
{"timestamp": "2025-07-18 12:38:08.137", "mode": "azero-full", "language": "en", "target": "en", "text": "tariff threats,", "text_tts": "tariff threats", "translate": "tariff threats,", "translate_tts": "tariff threats", "is_final": false, "emotion": "😰", "events": "🏠🔊📞🌠", "think": "", "wav_name": "b5a761d0-948a-4... |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.